JP2013540826A5 - - Google Patents

Download PDF

Info

Publication number
JP2013540826A5
JP2013540826A5 JP2013536904A JP2013536904A JP2013540826A5 JP 2013540826 A5 JP2013540826 A5 JP 2013540826A5 JP 2013536904 A JP2013536904 A JP 2013536904A JP 2013536904 A JP2013536904 A JP 2013536904A JP 2013540826 A5 JP2013540826 A5 JP 2013540826A5
Authority
JP
Japan
Prior art keywords
formulated
administration
crofelemer
daily
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013536904A
Other languages
English (en)
Japanese (ja)
Other versions
JP6063385B2 (ja
JP2013540826A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/058549 external-priority patent/WO2012058664A1/en
Publication of JP2013540826A publication Critical patent/JP2013540826A/ja
Publication of JP2013540826A5 publication Critical patent/JP2013540826A5/ja
Application granted granted Critical
Publication of JP6063385B2 publication Critical patent/JP6063385B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013536904A 2010-10-31 2011-10-31 Hiv関連の下痢を治療するための方法および組成物 Active JP6063385B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US61/408,622 2010-10-31
US40933510P 2010-11-02 2010-11-02
US61/409,335 2010-11-02
US41624910P 2010-11-22 2010-11-22
US61/416,249 2010-11-22
US201161434379P 2011-01-19 2011-01-19
US61/434,379 2011-01-19
PCT/US2011/058549 WO2012058664A1 (en) 2010-10-31 2011-10-31 Methods and compositions for treating hiv-associated diarrhea

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016151656A Division JP6310971B2 (ja) 2010-10-31 2016-08-02 Hiv関連の下痢を治療するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2013540826A JP2013540826A (ja) 2013-11-07
JP2013540826A5 true JP2013540826A5 (cg-RX-API-DMAC10.html) 2014-12-18
JP6063385B2 JP6063385B2 (ja) 2017-01-18

Family

ID=45994461

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013536904A Active JP6063385B2 (ja) 2010-10-31 2011-10-31 Hiv関連の下痢を治療するための方法および組成物
JP2016151656A Active JP6310971B2 (ja) 2010-10-31 2016-08-02 Hiv関連の下痢を治療するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016151656A Active JP6310971B2 (ja) 2010-10-31 2016-08-02 Hiv関連の下痢を治療するための方法および組成物

Country Status (20)

Country Link
US (4) US8962680B2 (cg-RX-API-DMAC10.html)
EP (1) EP2632550B1 (cg-RX-API-DMAC10.html)
JP (2) JP6063385B2 (cg-RX-API-DMAC10.html)
CN (2) CN103370101A (cg-RX-API-DMAC10.html)
AU (1) AU2011320155B2 (cg-RX-API-DMAC10.html)
BR (1) BR112013010774A2 (cg-RX-API-DMAC10.html)
CA (1) CA2816416C (cg-RX-API-DMAC10.html)
DK (1) DK2632550T3 (cg-RX-API-DMAC10.html)
EC (1) ECSP13012650A (cg-RX-API-DMAC10.html)
ES (1) ES2635435T3 (cg-RX-API-DMAC10.html)
HK (1) HK1249036A1 (cg-RX-API-DMAC10.html)
HU (1) HUE035393T2 (cg-RX-API-DMAC10.html)
MX (1) MX348184B (cg-RX-API-DMAC10.html)
PE (1) PE20140036A1 (cg-RX-API-DMAC10.html)
PH (1) PH12013500857A1 (cg-RX-API-DMAC10.html)
PL (1) PL2632550T3 (cg-RX-API-DMAC10.html)
PT (1) PT2632550T (cg-RX-API-DMAC10.html)
RU (1) RU2597746C2 (cg-RX-API-DMAC10.html)
WO (1) WO2012058664A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201303136B (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
PT2529626T (pt) 2006-05-01 2018-02-27 Napo Pharmaceuticals Inc Composições e métodos para tratamento ou prevenção do cancro do cólon
NZ572049A (en) 2006-05-01 2012-08-31 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
WO2012058664A1 (en) 2010-10-31 2012-05-03 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
JP2016505561A (ja) * 2012-12-07 2016-02-25 サリックス ファーマスーティカルズ,リミテッド Hiv関連下痢を治療する方法および組成物
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
AU2018275685B2 (en) 2017-05-31 2025-04-17 Napo Pharmaceuticals, Inc. Methods and compositions for treating bile acid diarrhea, diarrhea associated with small intestine resection or gallbladder removal, and short bowel syndrome
JP2020525407A (ja) 2017-05-31 2020-08-27 ナポ ファーマシューティカルズ インク.Napo Pharmaceuticals,Inc. 先天性下痢障害を治療するための方法及び組成物
JP2022523564A (ja) 2019-03-04 2022-04-25 アイオーカレンツ, インコーポレイテッド 機械学習を使用するデータ圧縮および通信
MX2022016367A (es) * 2020-06-19 2023-01-30 Napo Pharmaceuticals Inc Metodos y composiciones para el tratamiento de la diarrea inducida por quimioterapia.
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
JP4195728B2 (ja) 1996-10-16 2008-12-10 ナポ ファーマシューティカルズ,インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
WO2005074575A2 (en) * 2004-01-30 2005-08-18 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP1937655A1 (en) * 2005-06-22 2008-07-02 University of Massachusetts Hiv-1 protease inhibitors, and methods of making and using them
CA2633417A1 (en) 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl ureas for treating virus infections
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
NZ572049A (en) * 2006-05-01 2012-08-31 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
PT2529626T (pt) 2006-05-01 2018-02-27 Napo Pharmaceuticals Inc Composições e métodos para tratamento ou prevenção do cancro do cólon
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
WO2011024049A2 (en) 2009-08-26 2011-03-03 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
AU2010303577B2 (en) * 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
WO2012058664A1 (en) 2010-10-31 2012-05-03 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
WO2012101008A1 (en) 2011-01-27 2012-08-02 Glenmark Pharmaceuticals Limited Process for the production of proanthocyanidin polymeric composition
MX2014007635A (es) 2011-12-22 2014-09-22 Glenmark Pharmaceuticals Ltd Composicion farmaceutica no enterica que comprende crofelemer.
JP2016505561A (ja) 2012-12-07 2016-02-25 サリックス ファーマスーティカルズ,リミテッド Hiv関連下痢を治療する方法および組成物

Similar Documents

Publication Publication Date Title
Giannaki et al. Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review
Gamit et al. The effect of stretching exercise on primary dysmenorrhea in adult girls
RU2013123794A (ru) Способы и композиции для лечения вич-ассоциированной диареи
HRP20241454T1 (hr) Migalastat za upotrebu u postupcima liječenja fabrijeve bolesti kod pacijenata koji imaju mutaciju u gla genu
JP2016505561A5 (cg-RX-API-DMAC10.html)
RU2009119258A (ru) Способ лечения воспалительных заболеваний кишечника
Hjartarson et al. Intrathecal baclofen treatment an option in X-linked adrenoleukodystrophy
Bhatted et al. Ayurveda management of Palmoplantar Psoriasis (Vipadika)-a case report
CN118078795A (zh) 乙酸异丁香酚酯在制备预防和/或治疗炎症性肠病的药物中的用途
Pai et al. Rajaswala paricharya: Effect on menstrual cycle and its associated symptoms
Richter A randomized trial of pessary vs. behavioral therapy vs. combined therapy for treatment of stress urinary incontinence
JP4651747B1 (ja) 尿失禁のための治療剤
Nayak et al. Asterixis (flapping tremors) as an outcome of complex psychotropic drug interaction
Chee et al. Pityriasis rubra pilaris: Not just skin deep a case series
UA112652C2 (uk) Фармацевтична композиція для лікування передчасної еякуляції і спосіб лікування передчасної еякуляції
CN102688402A (zh) 一种治疗肝硬化肝腹水的药物
Vasileva Bruxism-description, epidemiology, etiology, classification
CN102416043B (zh) 一种治疗小儿脾虚腹泻的中药
Zouhri et al. Covid-19 with neuropathic pain symptom: A case-report
Lamina et al. Shortwave diathermy in the management of chronic pelvic inflammatory disease pain
Ghuse et al. Shashtika Shali Pinda Sweda in the management of child cerebral palsy spasticity
Geller et al. Impact of low back pain on Quality of Life: assessment by patient functionality questionnaire and treatment results using a combination of Diclofenac plus B vitamins or Diclofenac monotherapy
CN106727952A (zh) 一种治疗牙痛的药物组合物
Rosenberg Electroacupuncture is beneficial in women with stress incontinence
CN103301124B (zh) 一种治疗癫痫的药物组合物